Tag: GLP1
Genetic changes appear to help predict response to GLP-1 drugs for weight loss
Alterations in two specific genes may help forecast whether patients will experience significant weight loss when using GLP-1…
Beyond weight loss—how the GLP-1 story is evolving
Kendra Pierre-Louis: Filling in for Rachel Feltman, this is Kendra Pierre-Louis presenting Science Quickly from Scientific American.In early…
NIH whistleblower, GLP-1 telehealth, microbiome: Morning Rounds
The rise of telehealth has brought about significant changes in the way healthcare is delivered, with more and…
GLP-1 diabetes medications lower risk of all kinds of substance use disorders, study finds
A groundbreaking new study published in the BMJ suggests that GLP-1 medications, typically used to treat diabetes and…
Head-to-head trial shows Eli Lilly’s oral GLP-1 orforglipron outperforms oral semaglutide
A recent clinical trial compared two oral medications, orforglipron by Eli Lilly and oral semaglutide by Novo Nordisk,…
How GLP-1 use and eating disorders intersect
GLP-1 medications have undoubtedly revolutionized the field of medical weight management in a remarkably short period of time.…
New GLP-1 weight-loss drugs are coming—and they’re stronger than Wegovy and Zepbound
But some health professionals worry about the potential downsides of these powerful weight-loss medications. Dr. Carla Ramirez, an…
Here’s What Happens When You Stop GLP-1 Weight Loss Drugs
Challenges of Weight Loss Medication Adherence and Insurance CoverageHigh patient out-of-pocket costs and side effects are significant factors…
Humana’s CenterWell Pharmacy Launches Employer Venture Using Lilly’s GLP-1 Drugs
Humana’s CenterWell pharmacy has announced a new program in collaboration with Eli Lilly and Company to dispense GLP-1…
Stopping GLP-1 Drugs Triggers Weight Regain 4x Faster Than Ending Exercise : ScienceAlert
New Research Shows Rapid Weight Gain After Stopping Weight-Loss Drugs A recent study revealed that individuals who discontinue…
Why the weight, and heart risks, return after stopping GLP-1 drugsStopping obesity drugs means people regain weight and lose heart health benefitsÂ
Elizabeth Cooney, a cardiovascular disease reporter at STAT, delves into the complex world of weight loss drugs and…
Wegovy Pill Becomes First Oral GLP-1 Weight-Loss Drug Approved in U.S.
The U.S. has approved a groundbreaking weight-loss pill called Wegovy, which could potentially transform the healthcare industry. This…